Deal reached on compounding, track-and-trace bill; House/Senate votes pending
This article was originally published in Scrip
Executive Summary
A bicameral, bipartisan group of House and Senate lawmakers managed to hammer out a compromise bill that would create a new category of pharmacies engaged in large-volume compounding without individual prescriptions, known as outsourcing facilities, and clarify the FDA's role over those entities.